Continuous Manufacturing Under ICH Q13
ICH Q13 addresses continuous manufacturing (CM) — a mode of production where material moves through the process without the discrete stops that define a traditional batch — covering both processes designed as continuous from the start and existing batch processes converted to continuous operation. Finalized in 2022, it was ICH’s first guideline written specifically around this manufacturing mode rather than assuming batch processing as the default.
What an explainer is not
A topic explainer is SPEQ’s synthesis of what a practice involves, cited to the standards that govern it. It does not reproduce their text, and it does not determine which of them apply to your product or process.
[ POSITION IN THE FRAMEWORK ]
7 DIMENSIONS · 19 LINKSContinuous manufacturing forces a definition rather than a technology decision: with no discrete steps, a site must say what a batch is, how material is traced through it, and what happens to product made while the process was diverting.
06 · QUALITY MATURITY — CONTINUOUS MANUFACTURING UNDER ICH Q13, REACTIVE TO ADAPTIVE
Continuous equipment is operated as a faster batch line. Batch definition, traceability and diversion handling were never restated for it.
A batch definition exists and diversion logic is configured, but residence time distribution is a vendor figure rather than a measured property of this process.
Residence time distribution is determined experimentally, material traceability follows from it, and diversion decisions are tied to the disturbance they respond to.
Run length, start-up and shut-down are characterised as states with their own controls, and state-of-control is judged over time rather than at a sampling point.
The system detects and corrects disturbance before diversion is needed, and process understanding is deep enough that batch definition can be varied deliberately rather than fixed by caution.
SPEQ’s shared five-stage progression, labelled synthesis — not the FDA QMM rating scale. Where does your organization sit? Score your quality system →
07 · REGULATORY & EVIDENCE
GOVERNING STANDARDS · 4
Derived from the 4 standards SPEQ maps to this subject, across 1 regulatory body: ICH.
RECORDS & OBJECTIVE EVIDENCE
- The batch definition, and the material traceability model that follows from it
- Residence time distribution determination for this equipment and this formulation
- Diversion logic with the disturbances it responds to and the disposition of diverted material
- Start-up, shut-down and steady-state characterisation, including qualified run lengths
- Process monitoring data demonstrating a maintained state of control across a full run
COMMON INSPECTION FINDINGS
- A batch defined by convenience with no traceability model connecting input material to output units
- Residence time taken from the equipment vendor rather than measured for the actual process
- Diverted material dispositioned without a record linking it to the disturbance that caused diversion
- Start-up and shut-down excluded from validation while product from those states was released
- Run length extended in routine operation beyond what the validation data covers
Redefining “Batch” Without Discrete Steps
Traditional GMP batch definitions assume a discrete mixing or blending event that establishes homogeneity across a defined quantity of material. A continuous process has no such single event, so Q13 introduces the concept of defining a batch through time-based or quantity-based criteria applied to a continuous run — a definitional shift with real consequences for batch release, deviation scope, and recall boundaries.
Control Strategy Elements Unique to CM
A continuous-manufacturing control strategy needs to address material traceability through the process (so a specific input lot can be linked to the output material it became), residence time distribution (understanding how long material actually spends in each unit operation, since this varies rather than resetting between discrete batches), and a defined mechanism for diverting nonconforming material in real time without halting the entire run.
Dependence on Process Analytical Technology
Continuous processes are difficult to control without in-line or on-line measurement, because there is no natural pause point to pull a representative discrete sample the way a batch process allows. Q13-compliant control strategies accordingly lean heavily on the process-analytical-technology and real-time-release concepts already established under ICH Q8 and EU GMP Annex 17, applied continuously rather than at a single release checkpoint.
Converting an Existing Batch Process
Q13 explicitly covers the case of converting an already-approved batch process to continuous manufacturing, and expects the comparability logic familiar from other post-approval change frameworks — demonstrating the converted process delivers product of equivalent quality, not simply that the new equipment runs.
FREQUENTLY ASKED
How is a “batch” defined in continuous manufacturing?
Q13 allows a batch to be defined by a specified quantity of material or a specified period of continuous production, rather than by the discrete mixing event that defines a batch in traditional manufacturing.
Can an existing approved batch process be converted to continuous manufacturing?
Yes — Q13 explicitly addresses this scenario, and expects the manufacturer to demonstrate the converted process produces product of equivalent quality, following comparability-style reasoning.
Why does continuous manufacturing rely so heavily on PAT?
Without a natural discrete pause point for sampling, real-time in-line or on-line measurement is generally the only practical way to confirm product quality throughout an ongoing run.
Does Q13 apply to both drug substance and drug product manufacturing?
Yes — Q13 covers continuous manufacturing of both drug substances and drug products, and of the combined, integrated processes some CM implementations use.